Clover Health Investments Corp (NASDAQ:CLOV) shares, rose in value on Wednesday, February 12, with the stock price up by 0.68% to the previous day’s close as strong demand from buyers drove the stock to $4.47.
Actively observing the price movement in the last trading, the stock closed the session at $4.44, falling within a range of $4.331 and $4.58. The value of beta (5-year monthly) was 2.043. Referring to stock’s 52-week performance, its high was $4.87, and the low was $0.61. On the whole, CLOV has fluctuated by 20.16% over the past month.
With the market capitalization of Clover Health Investments Corp currently standing at about $2.24 billion, investors are eagerly awaiting this quarter’s results, scheduled for in March.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CLOV’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of CLOV currently trading nearly 1.43% and 19.03% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 60.19, while the 7-day volatility ratio is showing 4.76% which for the 30-day chart, stands at 6.00%. Furthermore, Clover Health Investments Corp (CLOV)’s beta value is 2.00, and its average true range (ATR) is 0.23.
A comparison of Clover Health Investments Corp (CLOV) with its peers suggests the former has fared considerably weaker in the market. CLOV showed an intraday change of 0.68% in last session, and over the past year, it grew by 338.24%%.
Data on historical trading for Clover Health Investments Corp (NASDAQ:CLOV) indicates that the trading volumes over the past 10 days have averaged 5.26 and over the past 3 months, they’ve averaged 5.57 million. According to company’s latest data on outstanding shares, there are 394.44 million shares outstanding.
Nearly 24.88% of Clover Health Investments Corp’s shares belong to company insiders and institutional investors own 17.11% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 15.08 million shares as on 2025-01-31, resulting in a short ratio of 2.17. According to the data, the short interest in Clover Health Investments Corp (CLOV) stood at 372.00 of shares outstanding as of 2025-01-31; the number of short shares registered in 2024-12-31 reached 15.96 million. The stock has risen by 41.90% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CLOV stock heading into the next quarter.
